Replies to post #167299 on Innovation Pharmaceuticals Inc (IPIX)

[jav0033]

Very well said. Cheers to you Amateur

[stevo99]

so does that mean you think the market is accurately predicting the next 12-18 months and readouts from multiple high potential clinical trials?

[BooDog]

The need for funding is far less desperate than people have been posting. Management has kudos big time for that. And it is in place to carry this for some time. Continued success with trials bumping this up to provide better opportunity for additional funding when it's needed, albeit dilutive, should be absorbed easily if it's timed right. Late and early spring time for 2 catalysts come to mind. The market has depreciated the bio sector from many trading 10 - 15 times their projected phase 3 pricing over the last couple years. I'm thinking this should still be closer to $4 - $5 right now. But that's just me. Bring on topline data for prurisol and move to a full phase 3 w/ funding in hand bump that up even more. This, like many others in the sector are massively undervalued. So no, this market is not reasonable.

IMO

[sox040713]

The market usually doesn't predict the outcome of the trials, the market reacts to it. The same can be said for partnership.

When Pharmacyclics was under $1, did the market got it right? On that particular day, maybe. But when you look at it today, the market clearly didn't predict that it'll be brought for $261.

In that sense market showed that it has very good intelligence and better than individual investors.